Both in Pharmaceuticals
Viatris vs Alnylam Pharmaceuticals
Over the past year VTRS returned +83.2% and ALNY returned −62.0%; their daily moves had a correlation of 0.13.
VTRS +83.2% ALNY −62.0%Growth of $1, one year, split-adjusted
| Metric | VTRS | ALNY |
|---|---|---|
| Price | $19.22 | $161.08 |
| Market cap | $22.08B | $21.57B |
| Today | +1.59% | +0.74% |
| 1 month | +9.6% | −28.1% |
| 6 months | +20.5% | −46.8% |
| Year to date | +54.4% | −59.5% |
| 1 year | +82.5% | −62.9% |
| Revenue growth (YoY) | +4.9% | +16.7% |
| Gross margin | 38.8% | 75.2% |
| Net margin | −3.2% | 148.6% |
| P/E (TTM) | — | 7.9× |
| Price / sales | 1.5× | 4.3× |
| Net cash | -$12.46B | $2.57B |
| Dividend yield | 2.50% | — |
| Volatility (60d) | 23.4% | 72.8% |
| Short % of float | 3.3% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).